Document is current
Any future updates will be listed below
-
Authors
Wilms, Anne E.
van der Weerd, Nelleke
van Harten, Thijs W.
Linstra, Katie M.
van Os, Hendrikus J. A.
de Boer, Irene
Kruit, Mark C.
Maassen van den Brink, Antoinette
Wermer, Marieke J. H.
Terwindt, Gisela M.
,
Appelman, Yolande
Baart, Sara
Benschop, Laura
Boersma, Eric
Brouwers, Laura
Budde, Ricardo
Cannegieter, Suzanne
Dam, Veerle
Eijkemans, Rene
Fauser, Bart
Ferrari, Michel
Franx, Arie
de Groot, Christianne
Gunning, Marlise
Hoek, Annemieke
Koffijberg, Erik
Koster, Wendy
Lagerweij, Giske
Lambalk, Nils
Laven, Joop
van der Lugt, Aad
Maas, Angela
Meun, Cindy
Middeldorp, Saskia
Moons, Karel GM
van Rijn, Bas
van Lennep, Jeanine Roeters
Roos-Hesselink, Jolien
Scheres, Luuk
van der Schouw, Yvonne T.
Steegers, Eric
Steegers, Regine
Velthuis, Birgitta
Zick, Bart
Zoet, Gerbrand
-
Funding
Funding for this research was provided by:
Dutch Heart Foundation (2013T083, 2013T083, 2013T083)
- License Information
-
More Information
Article History
Received: 5 January 2025
Accepted: 7 February 2025
First Online: 19 February 2025
Declarations
:
: The Medical Ethics Committee Leiden - Den Haag - Delft (METC-LDD) approved the CREW-MIST (P15.384) and WHISPER (P18.130) study protocols and all participants provided written informed consent prior to study participation.
: NW, KL and HO report no disclosures. MW was supported by personal grants from the Netherlands Organization for Scientific Research (VIDI Grant no. 91717337 and Aspasia grant). TH received support from the Dutch Heart Foundation and the Netherlands Organisation for Scientific Research (NWO), as part of their joint strategic research programme: “Earlier recognition of cardiovascular diseases”. AW and GT and IB report grant support by the European Community (101070917), Stichting Dioraphte (20010407), and the Clayco foundation. In addition, IB reports independent research support from the Dutch Heart Foundation (2020T065), and GT reports additional grants or consultancy support from Abbvie, Novartis, Lilly, Lundbeck, Organon, Pfizer, Teva, and independent support from the Dutch Research Council, Heart Foundation, Dutch Brain Foundation. AMB received honoraria and research/travel grants from Allergan/AbbVie, Amgen/Novartis, Eli Lilly, Pfizer, Satsuma, Teva, and Tonix, and independent support from the Dutch Research Council and ZonMw.
